| Year |
Citation |
Score |
| 2022 |
Chocron ES, Munkácsy E, Kim HS, Karpowicz P, Jiang N, Van Skike CE, DeRosa N, Banh AQ, Palavicini JP, Wityk P, Kalinowski L, Galvan V, Osmulski PA, Jankowska E, Gaczynska M, et al. Genetic and pharmacologic proteasome augmentation ameliorates Alzheimer's-like pathology in mouse and fly APP overexpression models. Science Advances. 8: eabk2252. PMID 35675410 DOI: 10.1126/sciadv.abk2252 |
0.312 |
|
| 2022 |
Dorigatti AO, Riordan R, Yu Z, Ross G, Wang R, Reynolds-Lallement N, Magnusson K, Galvan V, Perez VI. Brain cellular senescence in mouse models of Alzheimer's disease. Geroscience. PMID 35249206 DOI: 10.1007/s11357-022-00531-5 |
0.338 |
|
| 2021 |
Qiu S, Palavicini JP, Wang J, Gonzalez NS, He S, Dustin E, Zou C, Ding L, Bhattacharjee A, Van Skike CE, Galvan V, Dupree JL, Han X. Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer's disease-like neuroinflammation and cognitive impairment. Molecular Neurodegeneration. 16: 64. PMID 34526055 DOI: 10.1186/s13024-021-00488-7 |
0.317 |
|
| 2021 |
Van Skike CE, Hussong SA, Hernandez SF, Banh AQ, DeRosa N, Galvan V. mTOR attenuation with rapamycin reverses neurovascular uncoupling and memory deficits in mice modeling Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 33888602 DOI: 10.1523/JNEUROSCI.2144-20.2021 |
0.347 |
|
| 2019 |
Van Skike CE, Lin AL, Roberts Burbank R, Halloran JJ, Hernandez SF, Cuvillier J, Soto VY, Hussong SA, Jahrling JB, Javors MA, Hart MJ, Fischer KE, Austad SN, Galvan V. mTOR drives cerebrovascular, synaptic, and cognitive dysfunction in normative aging. Aging Cell. e13057. PMID 31693798 DOI: 10.1111/Acel.13057 |
0.386 |
|
| 2019 |
Kaeberlein M, Galvan V. Rapamycin and Alzheimer's disease: Time for a clinical trial? Science Translational Medicine. 11. PMID 30674654 DOI: 10.1126/Scitranslmed.Aar4289 |
0.325 |
|
| 2019 |
Hernandez SF, Skike CEV, DeRosa N, Galvan V. Mtor Promotes Bbb Breakdown In A Model Of Alzheimer’S Disease Innovation in Aging. 3. DOI: 10.1093/Geroni/Igz038.957 |
0.303 |
|
| 2019 |
Banh A, Pomilio C, Hussong SA, Galvan V. Mtor-Driven Alterations In The Brain Microvascular Proteome In Alzheimer’S Disease Innovation in Aging. 3. DOI: 10.1093/Geroni/Igz038.356 |
0.33 |
|
| 2019 |
Olson A, Hussong SA, Kayed R, Galvan V. TAU-INDUCED ASTROCYTE SENESCENCE: A NOVEL MECHANISM FOR NEURONAL DYSFUNCTION IN ALZHEIMER’S DISEASE Innovation in Aging. 3: S91-S92. DOI: 10.1093/Geroni/Igz038.348 |
0.393 |
|
| 2019 |
Hussong SA, Skike CEV, Olson AB, Hart MJ, Hernandez SF, Banh A, McAllen S, Kayed R, Galvan V. P4-148: Propagation Of Soluble Tau Aggregates In Brain Microvascular Endothelial Cells Promotes Cellular Senescence/Sasp And Blocks Enos Activation Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.3809 |
0.312 |
|
| 2018 |
Van Skike CE, Galvan V. A Perfect sTORm: The Role of the Mammalian Target of Rapamycin (mTOR) in Cerebrovascular Dysfunction of Alzheimer's Disease: A Mini-Review. Gerontology. PMID 29320772 DOI: 10.1159/000485381 |
0.407 |
|
| 2017 |
Van Skike CE, Jahrling JB, Olson AB, Sayre NL, Hussong SA, Ungvari ZI, Lechleiter JD, Galvan V. Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment. American Journal of Physiology. Heart and Circulatory Physiology. PMID 29351469 DOI: 10.1152/Ajpheart.00570.2017 |
0.433 |
|
| 2017 |
Marinesco S, Ungvari Z, Galvan V. Age-related impairment of metabovascular coupling during cortical spreading depolarizations. American Journal of Physiology. Heart and Circulatory Physiology. 313: H1209-H1212. PMID 28842440 DOI: 10.1152/Ajpheart.00514.2017 |
0.319 |
|
| 2017 |
Castillo-Carranza DL, Nilson AN, Van Skike CE, Jahrling JB, Patel K, Garach P, Gerson JE, Sengupta U, Abisambra J, Nelson P, Troncoso J, Ungvari Z, Galvan V, Kayed R. Cerebral Microvascular Accumulation of Tau Oligomers in Alzheimer's Disease and Related Tauopathies. Aging and Disease. 8: 257-266. PMID 28580182 DOI: 10.14336/Ad.2017.0112 |
0.406 |
|
| 2017 |
Jahrling JB, Lin AL, DeRosa N, Hussong SA, Van Skike CE, Girotti M, Javors M, Zhao Q, Maslin LA, Asmis R, Galvan V. mTOR drives cerebral blood flow and memory deficits in LDLR(-/-) mice modeling atherosclerosis and vascular cognitive impairment. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X17705973. PMID 28511572 DOI: 10.1177/0271678X17705973 |
0.389 |
|
| 2017 |
Galvan V. TOR drives neuronal and brain vascular dysfunction in mouse models of Alzheimer’s disease Experimental Gerontology. 94: 121. DOI: 10.1016/J.Exger.2017.02.049 |
0.346 |
|
| 2016 |
Cremers CM, Knoefler D, Gates S, Martin N, Dahl JU, Lempart J, Xie L, Chapman MR, Galvan V, Southworth DR, Jakob U. Polyphosphate: A Conserved Modifier of Amyloidogenic Processes. Molecular Cell. PMID 27570072 DOI: 10.1016/J.Molcel.2016.07.016 |
0.316 |
|
| 2016 |
Spilman PR, Corset V, Gorostiza O, Poksay KS, Galvan V, Zhang J, Rao R, Peters-Libeu C, Vincelette J, McGeehan A, Dvorak-Ewell M, Beyer J, Campagna J, Bankiewicz K, Mehlen P, et al. Netrin-1 Interrupts Amyloid-β Amplification, Increases sAβPPα in vitro and in vivo, and Improves Cognition in a Mouse Model of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 27060954 DOI: 10.3233/Jad-151046 |
0.404 |
|
| 2016 |
Galvan V, Hussong S, Halloran J, Burbank R, Fischer K, Austad S, Lin A, Cuvillier J, Van Skike C, Pomilio C. O4-03-05: TOR AS A KEY REGULATOR OF NEURONAL AND BRAIN VASCULAR FUNCTION IN MOUSE MODELS OF ALZHEIMER’S DISEASE Alzheimer's & Dementia. 12: P338-P339. DOI: 10.1016/J.Jalz.2016.06.622 |
0.332 |
|
| 2016 |
Pomilio C, Pavia P, Gorojod RM, Vinuesa A, Alaimo A, Galvan V, Kotler ML, Beauquis J, Saravia F. Glial alterations from early to late stages in a model of Alzheimer's disease: Evidence of autophagy involvement in Aβ internalization Hippocampus. 26: 194-210. DOI: 10.1002/Hipo.22503 |
0.339 |
|
| 2015 |
Lin AL, Jahrling JB, Zhang W, DeRosa N, Bakshi V, Romero P, Galvan V, Richardson A. Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer's disease. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 26721390 DOI: 10.1177/0271678X15621575 |
0.39 |
|
| 2015 |
Galvan V, Hart MJ. Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer's disease. Biochimica Et Biophysica Acta. PMID 26639036 DOI: 10.1016/J.Bbadis.2015.11.010 |
0.384 |
|
| 2015 |
Pomilio C, Pavia P, Gorojod RM, Vinuesa A, Alaimo A, Galvan V, Kotler ML, Beauquis J, Saravia F. Glial alterations from early to late stages in a model of Alzheimer's disease: Evidence of autophagy involvement in Aβ internalization. Hippocampus. 26: 194-210. PMID 26235241 DOI: 10.1002/hipo.22503 |
0.314 |
|
| 2015 |
Richardson A, Galvan V, Lin AL, Oddo S. How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story. Experimental Gerontology. 68: 51-8. PMID 25481271 DOI: 10.1016/J.Exger.2014.12.002 |
0.415 |
|
| 2014 |
Beauquis J, Vinuesa A, Pomilio C, Pavía P, Galván V, Saravia F. Neuronal and glial alterations, increased anxiety, and cognitive impairment before hippocampal amyloid deposition in PDAPP mice, model of Alzheimer's disease Hippocampus. 24: 257-269. PMID 24132937 DOI: 10.1002/Hipo.22219 |
0.437 |
|
| 2014 |
Sun YX, Ji X, Mao X, Xie L, Jia J, Galvan V, Greenberg DA, Jin K. Differential activation of mTOR Complex 1 Signaling in human brain with mild to severe Alzheimer's disease Journal of Alzheimer's Disease. 38: 437-444. PMID 23979023 DOI: 10.3233/Jad-131124 |
0.376 |
|
| 2014 |
Galvan V, Lin A, Zheng W, Halloran JJ, Burbank R, Hussong S, Hart M, Lechleiter J, Fox P. O2-12-02: TOR AND NO AS REGULATORS OF BRAIN VASCULAR FUNCTION IN A MOUSE MODEL OF AD Alzheimer's & Dementia. 10: P191-P192. DOI: 10.1016/J.Jalz.2014.04.223 |
0.34 |
|
| 2013 |
Lin AL, Pulliam DA, Deepa SS, Halloran JJ, Hussong SA, Burbank RR, Bresnen A, Liu Y, Podlutskaya N, Soundararajan A, Muir E, Duong TQ, Bokov AF, Viscomi C, Zeviani M, ... ... Galvan V, et al. Decreased in vitro mitochondrial function is associated with enhanced brain metabolism, blood flow, and memory in Surf1-deficient mice. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 33: 1605-11. PMID 23838831 DOI: 10.1038/Jcbfm.2013.116 |
0.334 |
|
| 2013 |
Lin AL, Zheng W, Halloran JJ, Burbank RR, Hussong SA, Hart MJ, Javors M, Shih YY, Muir E, Solano Fonseca R, Strong R, Richardson AG, Lechleiter JD, Fox PT, Galvan V. Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer's disease. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 33: 1412-21. PMID 23801246 DOI: 10.1038/Jcbfm.2013.82 |
0.436 |
|
| 2013 |
Pierce A, Podlutskaya N, Halloran JJ, Hussong SA, Lin PY, Burbank R, Hart MJ, Galvan V. Over-expression of heat shock factor 1 phenocopies the effect of chronic inhibition of TOR by rapamycin and is sufficient to ameliorate Alzheimer's-like deficits in mice modeling the disease Journal of Neurochemistry. 124: 880-893. PMID 23121022 DOI: 10.1111/Jnc.12080 |
0.403 |
|
| 2013 |
Beauquis J, Pavía P, Pomilio C, Vinuesa A, Podlutskaya N, Galvan V, Saravia F. Environmental enrichment prevents astroglial pathological changes in the hippocampus of APP transgenic mice, model of Alzheimer's disease Experimental Neurology. 239: 28-37. PMID 23022919 DOI: 10.1016/J.Expneurol.2012.09.009 |
0.428 |
|
| 2012 |
Halloran J, Hussong SA, Burbank R, Podlutskaya N, Fischer KE, Sloane LB, Austad SN, Strong R, Richardson A, Hart MJ, Galvan V. Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice. Neuroscience. 223: 102-13. PMID 22750207 DOI: 10.1016/J.Neuroscience.2012.06.054 |
0.355 |
|
| 2012 |
Sultana R, Robinson RA, Lange MB, Fiorini A, Galvan V, Fombonne J, Baker A, Gorostiza O, Zhang J, Cai J, Pierce WM, Bredesen DE, Butterfield DA. Do proteomics analyses provide insights into reduced oxidative stress in the brain of an Alzheimer disease transgenic mouse model with an M631L amyloid precursor protein substitution and thereby the importance of amyloid-beta-resident methionine 35 in Alzheimer disease pathogenesis? Antioxidants & Redox Signaling. 17: 1507-14. PMID 22500616 DOI: 10.1089/Ars.2011.4470 |
0.402 |
|
| 2012 |
Hart MJ, Glicksman M, Liu M, Sharma MK, Cuny G, Galvan V. Development of a high-throughput screen targeting caspase-8-mediated cleavage of the amyloid precursor protein Analytical Biochemistry. 421: 467-476. PMID 22178911 DOI: 10.1016/J.Ab.2011.11.020 |
0.352 |
|
| 2011 |
Robinson RA, Lange MB, Sultana R, Galvan V, Fombonne J, Gorostiza O, Zhang J, Warrier G, Cai J, Pierce WM, Bredesen DE, Butterfield DA. Differential expression and redox proteomics analyses of an Alzheimer disease transgenic mouse model: effects of the amyloid-β peptide of amyloid precursor protein. Neuroscience. 177: 207-22. PMID 21223993 DOI: 10.1016/J.Neuroscience.2011.01.005 |
0.409 |
|
| 2011 |
Vogt DL, Thomas D, Galvan V, Bredesen DE, Lamb BT, Pimplikar SW. Abnormal neuronal networks and seizure susceptibility in mice overexpressing the APP intracellular domain Neurobiology of Aging. 32: 1725-1729. PMID 19828212 DOI: 10.1016/J.Neurobiolaging.2009.09.002 |
0.354 |
|
| 2011 |
Pierce A, Podlutskaya N, Galvan V. P3-151: mTOR regulates chaperone networks and cognitive outcomes in mice modeling Alzheimer's disease Alzheimer's & Dementia. 7: S565-S565. DOI: 10.1016/J.Jalz.2011.05.1591 |
0.343 |
|
| 2010 |
Bredesen DE, John V, Galvan V. Importance of the caspase cleavage site in amyloid-β protein precursor Journal of Alzheimer's Disease. 22: 57-63. PMID 20847422 DOI: 10.3233/Jad-2010-100537 |
0.358 |
|
| 2010 |
Spilman P, Podlutskaya N, Hart MJ, Debnath J, Gorostiza O, Bredesen D, Richardson A, Strong R, Galvan V. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-β levels in a mouse model of alzheimer's disease Plos One. 5. PMID 20376313 DOI: 10.1371/Journal.Pone.0009979 |
0.399 |
|
| 2010 |
Butterfield DA, Galvan V, Lange MB, Tang H, Sowell RA, Spilman P, Fombonne J, Gorostiza O, Zhang J, Sultana R, Bredesen DE. In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid β-peptide of APP Free Radical Biology and Medicine. 48: 136-144. PMID 19854267 DOI: 10.1016/J.Freeradbiomed.2009.10.035 |
0.386 |
|
| 2010 |
Zhang J, Gorostiza OF, Tang H, Bredesen DE, Galvan V. Reversal of learning deficits in hAPP transgenic mice carrying a mutation at Asp664: A role for early experience Behavioural Brain Research. 206: 202-207. PMID 19751769 DOI: 10.1016/J.Bbr.2009.09.013 |
0.381 |
|
| 2009 |
Lourenço FC, Galvan V, Fombonne J, Corset V, Llambi F, Müller U, Bredesen DE, Mehlen P. Netrin-1 interacts with amyloid precursor protein and regulates amyloid-β production Cell Death and Differentiation. 16: 655-663. PMID 19148186 DOI: 10.1038/Cdd.2008.191 |
0.397 |
|
| 2009 |
Tang H, Wang Y, Xie L, Mao X, Won SJ, Galvan V, Jin K. Effect of neural precursor proliferation level on neurogenesis in rat brain during aging and after focal ischemia Neurobiology of Aging. 30: 299-308. PMID 17644223 DOI: 10.1016/J.Neurobiolaging.2007.06.004 |
0.315 |
|
| 2008 |
Galvan V, Zhang J, Gorostiza OF, Banwait S, Huang W, Ataie M, Tang H, Bredesen DE. Long-term prevention of Alzheimer's disease-like behavioral deficits in PDAPP mice carrying a mutation in Asp664 Behavioural Brain Research. 191: 246-255. PMID 18485495 DOI: 10.1016/J.Bbr.2008.03.035 |
0.414 |
|
| 2008 |
Banwait S, Galvan V, Zhang J, Gorostiza OF, Ataie M, Huang W, Crippen D, Koo EH, Bredesen DE. C-terminal cleavage of the amyloid-beta protein precursor at Asp664: a switch associated with Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 13: 1-16. PMID 18334752 DOI: 10.3233/Jad-2008-13101 |
0.422 |
|
| 2008 |
Nguyen TV, Galvan V, Huang W, Banwait S, Tang H, Zhang J, Bredesen DE. Signal transduction in Alzheimer disease: p21-activated kinase signaling requires C-terminal cleavage of APP at Asp664. Journal of Neurochemistry. 104: 1065-80. PMID 17986220 DOI: 10.1111/J.1471-4159.2007.05031.X |
0.42 |
|
| 2007 |
Galvan V, Jin K. Neurogenesis in the aging brain Clinical Interventions in Aging. 2: 605-610. PMID 18225461 DOI: 10.2147/Cia.S1614 |
0.32 |
|
| 2007 |
Galvan V, Bredesen DE. Neurogenesis in the adult brain: Implications for Alzheimer's disease Cns and Neurological Disorders - Drug Targets. 6: 303-310. PMID 18045158 DOI: 10.2174/187152707783220938 |
0.401 |
|
| 2007 |
Jin K, Galvan V. Endogenous neural stem cells in the adult brain Journal of Neuroimmune Pharmacology. 2: 236-242. PMID 18040856 DOI: 10.1007/S11481-007-9076-0 |
0.311 |
|
| 2007 |
Galvan V, Banwait S, Spilman P, Gorostiza OF, Peel A, Ataie M, Crippen D, Huang W, Sidhu G, Ichijo H, Bredesen DE. Interaction of ASK1 and the β-amyloid precursor protein in a stress-signaling complex Neurobiology of Disease. 28: 65-75. PMID 17719230 DOI: 10.1016/J.Nbd.2007.06.017 |
0.328 |
|
| 2007 |
Galvan V, Gorostiza OF, Banwait S, Ataie M, Logvinova AV, Sitaraman S, Carlson E, Sagi SA, Chevallier N, Jin K, Greenberg DA, Bredesen DE. Erratum: Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664 (Proceedings of the National Academy of Sciences of the United States of America (2006) 103, (7130-7135)) Proceedings of the National Academy of Sciences of the United States of America. 104. DOI: 10.1073/Pnas.0702342104 |
0.327 |
|
| 2006 |
Saganich MJ, Schroeder BE, Galvan V, Bredesen DE, Koo EH, Heinemann SF. Deficits in synaptic transmission and learning in amyloid precursor protein (APP) transgenic mice require C-terminal cleavage of APP. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 13428-36. PMID 17192425 DOI: 10.1523/Jneurosci.4180-06.2006 |
0.368 |
|
| 2006 |
Galvan V, Gorostiza OF, Banwait S, Ataie M, Logvinova AV, Sitaraman S, Carlson E, Sagi SA, Chevallier N, Jin K, Greenberg DA, Bredesen DE. Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664 Proceedings of the National Academy of Sciences of the United States of America. 103: 7130-7135. PMID 16641106 DOI: 10.1073/Pnas.0509695103 |
0.415 |
|
| 2006 |
Shaked GM, Kummer MP, Lu DC, Galvan V, Bredesen DE, Koo EH. Abeta induces cell death by direct interaction with its cognate extracellular domain on APP (APP 597-624). Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 1254-6. PMID 16636103 DOI: 10.1096/Fj.05-5032Fje |
0.317 |
|
| 2006 |
Van Skike CE, Hussong SA, Olson AB, Hernandez SF, Banh A, DeRosa N, Galvan V. P4-063: NEUROVASCULAR COUPLING DEFICITS ARISE PRIOR TO COGNITIVE DYSFUNCTION IN A MOUSE MODEL OF ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P1456-P1457. DOI: 10.1016/J.Jalz.2018.06.2466 |
0.339 |
|
| 2006 |
Galvan V, Gorostiza O, Zhang J, Banwait S, Ataie M, Sitaraman S, Crippen D, Sagi SA, Chevallier N, Jin K, Greenberg DA, Bredesen DE. O4-05-03: A key role of the C-terminal cleavage of APP in Alzheimer's disease Alzheimer's & Dementia. 2: S85-S85. DOI: 10.1016/J.Jalz.2006.05.329 |
0.32 |
|
| 2005 |
Cottrell BA, Galvan V, Banwait S, Gorostiza O, Lombardo CR, Williams T, Schilling B, Peel A, Gibson B, Koo EH, Link CD, Bredesen DE. A pilot proteomic study of amyloid precursor interactors in Alzheimer's disease. Annals of Neurology. 58: 277-89. PMID 16049941 DOI: 10.1002/Ana.20554 |
0.346 |
|
| 2004 |
Peel AL, Sorscher N, Kim JY, Galvan V, Chen S, Bredesen DE. Tau phosphorylation in Alzheimer's disease: potential involvement of an APP-MAP kinase complex. Neuromolecular Medicine. 5: 205-18. PMID 15626821 DOI: 10.1385/Nmm:5:3:205 |
0.355 |
|
| 2004 |
Jin K, Galvan V, Xie L, Mao XO, Gorostiza OF, Bredesen DE, Greenberg DA. Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APP Sw,Ind) mice Proceedings of the National Academy of Sciences of the United States of America. 101: 13363-13367. PMID 15340159 DOI: 10.1073/Pnas.0403678101 |
0.44 |
|
| 2002 |
Galvan V, Chen S, Lu D, Logvinova A, Goldsmith P, Koo EH, Bredesen DE. Caspase cleavage of members of the amyloid precursor family of proteins. Journal of Neurochemistry. 82: 283-94. PMID 12124429 DOI: 10.1046/J.1471-4159.2002.00970.X |
0.357 |
|
| 2002 |
Galván VV, Chen J, Weinberger NM. Differential thresholds of local field potentials and unit discharges in rat auditory cortex. Hearing Research. 167: 57-60. PMID 12117530 DOI: 10.1016/S0378-5955(02)00333-7 |
0.511 |
|
| 2002 |
Galván VV, Weinberger NM. Long-term consolidation and retention of learning-induced tuning plasticity in the auditory cortex of the guinea pig. Neurobiology of Learning and Memory. 77: 78-108. PMID 11749087 DOI: 10.1006/Nlme.2001.4044 |
0.524 |
|
| 2001 |
Galván VV, Chen J, Weinberger NM. Long-term frequency tuning of local field potentials in the auditory cortex of the waking guinea pig. Journal of the Association For Research in Otolaryngology : Jaro. 2: 199-215. PMID 11669394 DOI: 10.1007/S101620010062 |
0.511 |
|
| Show low-probability matches. |